The modulation of CB1 activity may be used as a therapeutic strategy in retinal degeneration either alone or in combination with accepted treatments and deserves further studies in other retinal degeneration models as well as in human retinal diseases. The gene discussed is CNR1; the disease is Abnormal retinal morphology.